Jeremy Bender

CHIEF EXECUTIVE OFFICER

Jeremy Bender (CHIEF EXECUTIVE OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in DAWN. The largest single filing was $179K of DAWN (15,459 sh × $11.60, as filed), executed Feb 17.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$321K

shares × price, as filed

Last traded

Feb 17

Filed Feb 18

Open performance→

Volume by month

Buys $0 Sells $713K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 2 filings

Sector per market data · by filing · past 12 months

Most traded names

DAWN DAWN DAWN · 0 buys · 5 sells 5 filings

Recent filings

DAWNSALE Day One Biopharmaceuticals, Inc. View filing → $179K
15,459 sh × $11.60
Exec Feb 17
Filed Feb 18 · 5:30 PM ET DAWNSALE Day One Biopharmaceuticals, Inc. View filing → $142K
15,894 sh × $8.91
Exec Nov 17 2025
Filed Nov 18 2025 · 5:30 PM ET DAWNSALE Day One Biopharmaceuticals, Inc. View filing → $109K
16,058 sh × $6.77
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET DAWNSALE Day One Biopharmaceuticals, Inc. View filing → $144K
12,048 sh × $11.96
Exec Feb 18 2025
Filed Feb 21 2025 · 5:30 PM ET † DAWNSALE Day One Biopharmaceuticals, Inc. View filing → $139K
10,554 sh × $13.21
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET